Pharmaceutical Expenditure Governance in the UK and Italy
European Journal of Health Law · 2026
DOI: 10.1163/15718093-bja10168 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Health Law, 2026. Verfasst von Alice Cauduro. Beteiligte Einrichtung: Department of Law, University of Turin 9314 Lungo Dora Siena 100, 10153 Turin Italy. Hauptthemen laut MEDLINE: Drug Costs, Health Expenditures. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
The governance of pharmaceutical expenditure is a crucial issue in ensuring access to pharmaceutical care, especially in countries with universal healthcare systems where both the pricing and reimbursement of medicines are managed by public authorities. Through a comparative analysis of the challenges and policy solutions adopted by the United Kingdom and Italy, this article focuses on key issues related to the management of reimbursed medicine costs: the allocation of competences among public authorities, cost-effectiveness assessment, expenditure control, and price transparency. It highlights critical issues and outlines future research perspectives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Law, University of Turin 9314 Lungo Dora Siena 100, 10153 Turin Italy.
ORCID-Profile: Alice Cauduro
Zitieren
APA
Cauduro, A. (2026). Pharmaceutical Expenditure Governance in the UK and Italy. European Journal of Health Law. https://doi.org/10.1163/15718093-bja10168
Vancouver
Cauduro A. Pharmaceutical Expenditure Governance in the UK and Italy. European Journal of Health Law. 2026. doi:10.1163/15718093-bja10168
BibTeX
@article{Cauduro2026,
author = {Cauduro, Alice},
title = {Pharmaceutical Expenditure Governance in the UK and Italy},
journal = {European Journal of Health Law},
year = {2026},
doi = {10.1163/15718093-bja10168}
}
EUVIMED